Diagnosis of hypochondroplasia: international Delphi consensus recommendations

Andrew Dauber1,2, Moira S Cheung3, Julie Hoover-Fong4

  • 1Division of Endocrinology, Children's National Hospital, Washington, DC, USA.

Insights

Hypochondroplasia, a skeletal dysplasia, often presents diagnostic challenges. New international guidelines offer standardized criteria for timely and accurate diagnosis, improving patient care.

Area of Science:

  • Genetics and Developmental Biology
  • Medical Diagnostics
  • Skeletal Dysplasias

Background:

  • Hypochondroplasia, caused by FGFR3 variants, leads to disproportionate short stature and macrocephaly.
  • Diagnostic uncertainty is common, especially in early childhood and mild/atypical cases, causing delayed management and care planning challenges.
  • Affected individuals face medical complications, psychosocial issues, and require multidisciplinary care.

Purpose of the Study:

  • To develop consensus-based diagnostic recommendations for hypochondroplasia.
  • To address unmet needs in diagnosis, management, and care planning for hypochondroplasia patients.
  • To create a practical framework for global clinical practice and research.

Main Methods:

  • An international, multidisciplinary expert panel and patient representatives convened.
  • A modified two-stage Delphi approach was employed to reach consensus.
  • Consensus was defined as ≥70% of respondents rating statements ≥70 (0-100 scale).

Main Results:

  • Integrated clinical, anthropometric, radiographic, neuroimaging, and genetic criteria were used.
  • Diagnostic categories with major and minor criteria were defined for diverse healthcare settings.
  • Guidance on molecular testing, radiographic evaluation, and brain MRI was provided.

Conclusions:

  • The recommendations aim to standardize timely and accurate diagnosis of hypochondroplasia.
  • This framework will aid clinical practice and research efforts.
  • Improved diagnostic accuracy can lead to better patient outcomes and care planning.